Feasibility of a brief intervention for medication-overuse headache in primary care – a pilot study

BMC Research Notes

Christofer Lundqvist¹  Michael Bjørn Russell⁴  Jørund Straand²  Espen Saxhaug Kristoffersen³ 

[1] Department of Neurology, Akershus University Hospital, Nordbyhagen, Norway;Department of General Practice, Institute of Health and Society, University of Oslo, Blindern, PO Box 1130, 0318 Oslo, Norway;Health Service Research Centre, Research Centre, Akershus University Hospital, PO Box 95, 1478 Lørenskog, Norway;Institute of Clinical Medicine, Akershus University Hospital, University of Oslo, Nordbyhagen, Norway

关键词: Pilot study;    Feasibility study;    Severity of dependence scale;    General practice;    Brief intervention;    Migraine;    Medication-overuse headache;    Chronic headache;   

Others  :  1134191
DOI  :  10.1186/1756-0500-7-165

 received in 2013-07-23, accepted in 2014-03-10,  发布年份 2014

【 摘 要 】

Background

Medication-overuse headache (MOH) is a common problem in primary care. Brief intervention (BI) has successfully been used for detoxification from overuse of alcohol and drugs. The aim of this pilot study was to develop and test methodology, acceptability and logistics for a BI for MOH in primary care.

Findings

Observational feasibility study of an intervention in a Norwegian general practice population.

Six general practitioners (GPs) were recruited. A screening questionnaire for MOH was sent to all 18–50 year old patients on these GPs` list. GPs were taught BI, which was applied to MOH patients as follows: Severity of dependence scale (SDS) scores were collected and individual feedback was given of the relationship between the SDS, medication overuse and headache. Finally, advice to reduce medication was given. Patients were invited to a headache interview three months after the BI. Main outcomes were feedback from GPs/patients about the feasibility and logistics of the study design, screening/recruitment process, BI and headache interviews. Efficacy and patient-related outcomes were not focused. The patients reported a high degree of acceptability of the methodology. The GPs reported the BI to be feasible to implement within a busy practice and to represent a new and improved instrument for communication with MOH patients. The BI requires further testing in a randomised controlled trial (RCT) in order to provide evidence of efficacy.

Conclusion

This feasibility study will be used to improve the BI for MOH and the design of a cluster-RCT.

Trial registration

ClinicalTrials.gov: NCT01078012 (Initially registered as controlled efficacy trial but changed to observational study).

【 授权许可】

   
2014 Kristoffersen et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Latinovic R, Gulliford M, Ridsdale L: Headache and migraine in primary care: consultation, prescription, and referral rates in a large population. J Neurol Neurosurg Psychiatry 2006, 77:385-387.
• [2]Kristoffersen ES, Grande RB, Aaseth K, Lundqvist C, Russell MB: Management of primary chronic headache in the general population: the Akershus study of chronic headache. J Headache Pain 2012, 13:113-120.
• [3]Kristoffersen ES, Lundqvist C, Aaseth K, Grande RB, Russell MB: Management of secondary chronic headache in the general population: the Akershus study of chronic headache. J Headache Pain 2013, 14:5. BioMed Central Full Text
• [4]Jonsson P, Hedenrud T, Linde M: Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia 2011, 31:1015-1022.
• [5]Castillo J, Munoz P, Guitera V, Pascual J: Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache 1998, 39:190-196.
• [6]Aaseth K, Grande RB, Kvaerner KJ, Gulbrandsen P, Lundqvist C, Russell MB: Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akershus study of chronic headache. Cephalalgia 2008, 28:705-713.
• [7]Lantéri-Minet M, Auray JP, El Hasnaoui A, Dartigues JF, Duru G, Henry P, Lucas C, Pradalier A, Chazot G, Gaudin AF: Prevalence and description of chronic daily headache in the general population in France. Pain 2003, 102:143-149.
• [8]Colás R, Muñoz P, Temprano R, Gómez C, Pascual J: Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004, 62:1338-1342.
• [9]Diener HC, Limmroth V: Medication-overuse headache: a worldwide problem. Lancet Neurol 2004, 3:475-483.
• [10]Evers S, Marziniak M: Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol 2010, 9:391-401.
• [11]Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barre J, Katsarava Z, Lainez JM, Lampl C, Lanteri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Andree C: The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 2012, 19:703-711.
• [12]Headache Classification Committee of the International Headache Society: The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24(Suppl 1):9-160.
• [13]Erratum Cephalalgia 2006, 26:360.
• [14]Olesen J, Bousser M-GG, Diener H-CC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ, Göbel H: New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006, 26:742-746.
• [15]Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Steiner TJ: The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia 2005, 25:460-465.
• [16]Rossi P, Jensen R, Nappi G, Allena M, Consortium COMOESTAS: A narrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain 2009, 10:407-417.
• [17]Evers S, Jensen R: European Federation of Neurological Societies: Treatment of medication overuse headache–guideline of the EFNS headache panel. Eur J Neurol 2011, 18:1115-1121.
• [18]Olesen J: Detoxification for medication overuse headache is the primary task. Cephalalgia 2012, 32:420-422.
• [19]Zeeberg P, Olesen J, Jensen R: Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 2006, 66:1894-1898.
• [20]Fuh JL, Wang SJ, Lu SR, Juang KD: Does medication overuse headache represent a behavior of dependence? Pain 2005, 119:49-55.
• [21]Calabresi P, Cupini LM: Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci 2005, 26:62-68.
• [22]Ferrari A, Cicero AF, Bertolini A, Leone S, Pasciullo G, Sternieri E: Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ). Cephalalgia 2006, 26:187-193.
• [23]Radat F, Lanteri-Minet M: What is the role of dependence-related behavior in medication-overuse headache? Headache 2010, 50:1597-1611.
• [24]Saper JR, Hamel RL, Lake AE III: Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia 2005, 25:545-546.
• [25]Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J: The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995, 90:607-614.
• [26]Grande RB, Aaseth K, Saltyte Benth J, Gulbrandsen P, Russell MB, Lundqvist C: The Severity of Dependence Scale detects people with medication overuse: the Akershus study of chronic headache. J Neurol Neurosurg Psychiatry 2009, 80:784-789.
• [27]Lundqvist C, Aaseth K, Grande RB, Benth JS, Russell MB: The severity of dependence score correlates with medication overuse in persons with secondary chronic headaches. The Akershus study of chronic headache. Pain 2010, 148:487-491.
• [28]Babor TF, Higgins-biddle JC: Brief Intervention for hazardous and harmful drinking - a manual for use in primary care. Geneva: World Health Organization; 2001.
• [29]Kaner EF, Beyer F, Dickinson HO, Pienaar E, Campbell F, Schlesinger C, Heather N, Saunders J, Burnand B: Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev 2007, CD004148.
• [30]Bashir K, King M, Ashworth M: Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. Br J Gen Pract 1994, 44:408-412.
• [31]Humeniuk R, Ali R, Babor T, Souza-Formigoni ML, de Lacerda RB, Ling W, McRee B, Newcombe D, Pal H, Poznyak V, Simon S, Vendetti J: A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries. Addiction 2012, 107:957-966.
• [32]Grande RB, Aaseth K, Benth JS, Lundqvist C, Russell MB: Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J Neurol 2011, 18:129-137.
• [33]Rossi P, Di LC, Faroni J, Cesarino F, Nappi G, Di Lorenzo C: Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 2006, 26:1097-1105.
• [34]Rossi P, Faroni JV, Nappi G: Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur J Neurol 2011, 18:396-401.
• [35]Kraemer HC, Mintz J, Noda A, Tinklenberg J, Yesavage JA: Cautions regarding the use of pilot studies to guide power calculations for study proposals. Arch Gen Psychiatry 2006, 63:484-489.
• [36]van Teijlingen E, Hundley V: The importance of pilot studies. Nurs Stand 1998, 16:33-36.
• [37]Lancaster G, Dodd S, Williamson PR: Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract 2004, 10:307-312.
• [38]Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, Robson R, Thabane M, Giangregorio L, Goldsmith CH: A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol 2010, 10:1. BioMed Central Full Text
• [39]Bien TH, Miller WR, Tonigan JS: Brief interventions for alcohol problems: a review. Addiction 1993, 88:315-335.
• [40]Russell MB, Rasmussen BK, Brennum J, Iversen HK, Jensen RHA, Olesen J: Presentation of a new instrument: the diagnostic headache diary. Cephalalgia 1992, 12:369-374.
• [41]Hagen K, Jensen R, Boe MG, Stovner LJ: Medication overuse headache: a critical review of end points in recent follow-up studies. J Headache Pain 2010, 11:373-377.
• [42]Kristoffersen ES, Straand J, Benth JS, Russell MB, Lundqvist C: Study protocol: Brief intervention for medication overuse headache - a double-blinded cluster randomised parallel controlled trial in primary care. BMC Neurol 2012, 12:70. BioMed Central Full Text
• [43]Norwegian Prescription Database [http://www.reseptregisteret.no webcite]
• [44]Jensen R, Tassorelli C, Rossi P, Allena M, Osipova V, Steiner T, Sandrini G, Olesen J, Nappi G, Basic Diagnostic Headache Diary Study Group: A basic diagnostic headache diary (BDHD) is well accepted and useful in the diagnosis of headache. a multicentre European and Latin American study. Cephalalgia 2011, 31:1549-1560.
• [45]Beich A, Gannik D, Malterud K: Screening and brief intervention for excessive alcohol use: qualitative interview study of the experiences of general practitioners. BMJ 2002, 325:870.
• [46]Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J: Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse. Substance Abuse 2007, 28:7-30.
• [47]Ware JE Jr, Snow K, Gandek B: SF-36 health survey. Manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center; 1993.
• [48]Kosinski M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH, Batenhorst A, Cady R, Dahlof CG, Dowson A, Tepper S: A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 2003, 12:963-974.
• [49]Stewart WF, Lipton RB, Dowson AJ, Sawyer J: Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology 2001, 56:S20-S28.